Illumina Ventures

We are the premier genomics and precision health venture firm supporting early-stage companies to improve human health.

Independently managed, we bring depth of knowledge, decades of domain expertise, strong operating experience, and a strategic relationship with Illumina (NASDAQ: ILMN). This enables us to identify and build companies that will transform healthcare and our world. We operate as true partners to entrepreneurs developing breakthrough science and technology into market-leading companies. Through Illumina Ventures Labs, we accelerate value creation for early-stage genomics start-ups via access to capital, sequencing, mentorship, and fully equipped genomics lab capabilities.